Who Paid My Doc
TrueBeam
Device Oncology
PDI 00899475002004
General payments
$1,812,741
Research payments
$1,838,852
Through program year 2025, $1,812,741 in general payments and $1,838,852 in research payments were reported against TrueBeam (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $444,614 | 286 |
| 2025 | Research | $174,350 | 6 |
| 2024 | General | $590,636 | 322 |
| 2024 | Research | $592,641 | 12 |
| 2023 | General | $349,284 | 336 |
| 2023 | Research | $656,132 | 16 |
| 2022 | General | $172,563 | 259 |
| 2022 | Research | $243,480 | 8 |
| 2021 | General | $255,644 | 130 |
| 2021 | Research | $172,248 | 7 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 19 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 38 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,333 general · 49 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.